TSX open
Loading markets…

Advertisement

Stocks

Why Extendicare Inc stock is rising today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:EXE.TO

Follow EXE

Photos provided by Pexels

Extendicare Inc's stock is on the rise, reflecting strong performance metrics and strategic growth.

Extendicare Inc (EXE.TO) is up today, gaining 3.13% in the market after releasing impressive Q2 earnings that showed significant revenue growth and successful integration of recent acquisitions.

Advertisement

Extendicare Inc

EXE.TO

Full stock page →

EXE.TO

Extendicare Inc

Source:WealthAwesomeWealthAwesome
↓ $1.07 (-3.72%)
120 day period
$26.68$32.66$38.63Apr 17Jul 14Oct 7

Market cap

$2.64B

P/E

21.2x

Div. yield

1.92%

Div. / share

$0.51

52W high

$38.98

52W low

$14.17

1W change

-6.78%

Beta

1.07

Analyst Price Targets

Based on analyst covering EXE · as of Sep 17, 2026

📈

Wall Street analysts forecast EXE stock price to rise 43.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$39.83

+43.3% Upside

Current Price

C$27.79

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on EXE's historical volatility

HistoricalForecast68%95%
C$15.41C$20.29C$25.16C$30.04C$34.92C$39.79TodayJun 1Aug 5Oct 7Nov 19Jan 2Feb 14

30-Day Vol

31.8%

Annualized

90-Day Vol

31.6%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$23.25

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$26.18C$23.46 – C$29.23
60 trading daysC$24.67C$21.12 – C$28.82
90 trading daysC$23.25C$19.22 – C$28.12

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider Extendicare's strong growth trajectory and focus on integration as key factors driving its stock performance.

Extendicare's Revenue Soars by 59.4%

The substantial revenue increase highlights the successful integration of CBI Home Health and other acquisitions, positioning Extendicare for continued growth.

Bull case

The company reported an impressive 59.4% increase in revenue to C$611 million, driven by successful acquisitions that are exceeding initial EBITDA expectations.

Bear case

Despite the positive outlook, investors should stay cautious about potential integration challenges and the impact of rising labor costs on profit margins.

Strong Q2 Earnings Drive Stock Performance

Advertisement

Extendicare Inc's stock is climbing today, thanks to a strong Q2 earnings report. The company reported a 59.4% revenue increase to C$611 million, largely due to the successful integration of its recent acquisitions, including CBI Home Health. Management noted that all three acquisitions are performing better than expected, which has positively influenced investor sentiment.

Focus on Integration and Growth

Management is prioritizing the integration of CBI Home Health, expecting to achieve C$7.4 million in annual cost synergies once the integration is complete. The company is also advancing several long-term care redevelopment projects, which are expected to significantly enhance its operational capacity. This growth strategy is crucial for maintaining momentum in the competitive healthcare sector.

Market Outlook and Considerations

While Extendicare's stock is rising today, investors should be aware of potential challenges, especially regarding integration and labor cost pressures. The company has indicated that it does not plan to pursue significant additional acquisitions until late 2027, which could affect future growth. Nonetheless, the current trajectory suggests a positive outlook for Extendicare as it continues to expand its market presence.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 14, 2026
Last Updated: September 23, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement